医用臭氧疼痛触发点注射治疗腰部肌筋膜疼痛综合征的效果与安全性

目的：：探索医用臭氧疼痛触发点注射治疗腰部肌筋膜疼痛综合征( MPS)的临床疗效及安全性。方法：将118例入选临床研究的 MPS 患者采用随机、单盲法分作两组，其中对照组59例使用消炎镇痛液注射治疗而研究组59例应用低浓度医用臭氧注射治疗，评价两组临床疗效及安全性。结果：两组治疗前 VAS 评分及腰背功能活动评分比较差异均无统计学意义( P >0.05)。两组治疗后 VAS评分及腰背功能活动评分均较治疗前明显减少，差异有统计学意义( P <0.05)；且观察组与对照组比较明显减少，差异有统计学意义(P<0.05)。观察组治疗有效率(89.83％)高于对照组(71.19％)，差异具有统计学意义(P<0.05)。观察组不良反应发生率(1.69％)较对照组降低(23.73％)，安全性更好，差异具有统计学意义(P<0.05)。结论：医用臭氧疼痛触发点注射治疗腰部 MPS 疗效更好，安全性更高，适合临床进行广泛推广和应用。

The Effect and Safety of Medical Ozone Pain Trigger Point Injection in Treatment for Lumbar Myofascial Pain Syndrome

Objective: To explore the effect and safety of medical ozone pain trigger point injection in treatment of lumbar myofascial pain syndrome (MPS). Methods: 118 patients with MPS, enrolled in the clin-ical research, according to the treatment sequence number, were randomly divided into two groups, 59 cases in control group used anti-inflammatory analgesic injection, while 59 cases in the experimental group treated with low concentration of medical ozone injection, clinical curative effect and safety of the two groups were e-valuated. Results:After treatment, the VAS score of the observation group was (1.49±0.25) and low back function activities score was (0.31±0.11), significantly reduced when compared with the group before treat-ment and control group, the difference was statistically significant (P <0.05). The treatment efficiency (89. 83%) of the observation group was significantly higher than the control group (71.19%), and the difference was statistically significant (P<0.05). The adverse reaction rate of the observation group (1.69%) was signifi-cantly lower than the control group(23.73%), with better security, and the difference was statistically signifi-cant(P<0.05). Conclusion: Medical ozone pain trigger point injection in treating lumbar MPS has a better curative effect, with high safety, which is suitable for clinical popularization and application.